Bajaj Healthcare Ltd (IN:BAJAJHCARE)
:BAJAJHCARE
Want to see IN:BAJAJHCARE full AI Analyst Report?
BAJAJHCARE Stock Chart & Stats
₹418.50
-₹31.80(-5.51%)
At close: 4:00 PM EST
₹418.50
-₹31.80(-5.51%)
Day’s Range― - ―
52-Week Range₹272.45 - ₹608.60
Previous CloseN/A
Volume215.90K
Average Volume (3M)4.99K
Market Cap
₹10.06B
Enterprise Value₹11.73B
Total Cash (Recent Filing)₹140.05M
Total Debt (Recent Filing)₹2.38B
Price to Earnings (P/E)58.3
Beta1.21
Next Earnings
Aug 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.24%
Share Statistics
EPS (TTM)14.39
Shares Outstanding33,662,663
10 Day Avg. Volume2,706
30 Day Avg. Volume4,987
Financial Highlights & Ratios
PEG Ratio-0.93
Price to Book (P/B)1.72
Price to Sales (P/S)1.50
P/FCF Ratio-149.92
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Integrated Manufacturing Footprint (APIs, Intermediates, Formulations)A vertically integrated manufacturing model spanning APIs, intermediates and finished dosages supports diversified revenue streams and customer types (domestic, export, contract CMO). This durability reduces single-segment exposure and enables scale advantages, long-term customer relationships and margin stability.
Improving Leverage And Capital StructureA materially lower debt-to-equity ratio increases financial resilience and lowers insolvency risk during industry cyclicality. Improved leverage expands capacity for reinvestment or acquisitions, reducing refinancing pressure and supporting more predictable interest costs over the medium term.
Revenue Recovery With Better Gross MarginsA return to revenue growth alongside improved gross margins suggests demand normalization and better production economics. Sustainable higher gross margins enhance the ability to absorb SG&A or below-the-line volatility, supporting longer-term profitability if volumes and pricing remain stable.
Bears Say
Net Margin Compression And Earnings VolatilitySharp swings in net margin and prior loss years indicate earnings are sensitive to below-the-line items, one-offs or cost shocks. Low and volatile net margins reduce retained earnings, weaken return metrics, and increase the company's exposure to adverse cycles over the next several quarters.
Weak Cash Conversion; Negative Free Cash Flow HistoryInconsistent conversion of earnings into free cash and repeated negative FCF raises funding and liquidity risk. Reliance on external financing or equity to support capex and working capital could constrain strategic flexibility and raise costs if margins or cash flows weaken.
Material Absolute Debt StockEven with improved ratios, a sizable absolute debt burden heightens interest expense sensitivity and limits leeway for expansion during slowdowns. If profitability remains thin, servicing this debt could pressure cash flows and restrict investment for product development or capacity upgrades.
Bajaj Healthcare Ltd News
BAJAJHCARE FAQ
What was Bajaj Healthcare Ltd’s price range in the past 12 months?
Bajaj Healthcare Ltd lowest stock price was ₹272.45 and its highest was ₹608.60 in the past 12 months.
What is Bajaj Healthcare Ltd’s market cap?
Bajaj Healthcare Ltd’s market cap is ₹10.06B.
When is Bajaj Healthcare Ltd’s upcoming earnings report date?
Bajaj Healthcare Ltd’s upcoming earnings report date is Aug 04, 2026 which is in 73 days.
How were Bajaj Healthcare Ltd’s earnings last quarter?
Bajaj Healthcare Ltd released its earnings results on May 08, 2026. The company reported -₹7.16 earnings per share for the quarter, missing the consensus estimate of N/A by -₹7.16.
Is Bajaj Healthcare Ltd overvalued?
According to Wall Street analysts Bajaj Healthcare Ltd’s price is currently Overvalued.
Does Bajaj Healthcare Ltd pay dividends?
Bajaj Healthcare Ltd pays a Annually dividend of ₹1 which represents an annual dividend yield of 0.24%. See more information on Bajaj Healthcare Ltd dividends here
What is Bajaj Healthcare Ltd’s EPS estimate?
Bajaj Healthcare Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bajaj Healthcare Ltd have?
Bajaj Healthcare Ltd has 33,662,663 shares outstanding.
What happened to Bajaj Healthcare Ltd’s price movement after its last earnings report?
Bajaj Healthcare Ltd reported an EPS of -₹7.16 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.883%.
Which hedge fund is a major shareholder of Bajaj Healthcare Ltd?
Currently, no hedge funds are holding shares in IN:BAJAJHCARE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Bajaj Healthcare Ltd
Bajaj HealthCare Limited, a pharmaceutical company, develops, manufactures, and supplies amino acids, nutritional supplements, and active pharmaceutical ingredients (APIs) for pharmaceutical, nutraceuticals, and food industries in India and internationally. The company's product portfolio consists of various APIs in the therapeutic categories of anti-diabetic, antibiotic, antiviral, antiplatelet, antifungal, antihelmintic, iron-chelating agent, anticonvulsant, growth stimulant, non-steroidal anti-inflammatory drugs, antihypertensive, anthelmintics, anti-asthmatic, antioxidant, urinary tract infection, anti-histamine, weight reducing, venous disease, antimalarial, vitamin c, disinfectant/ antiseptic, stimulant, anticonvulsant, lipotropic agents, nootropic, vasoprotective/ antihemorrhagic, cardiovascular agent, food supplements, anti-anemic, amino acids, antiasthmatic / bronchodilator, nutritional supplement, and minerals. It also provides formulations in the form of tablets, capsules, and powder, as well as impurities. In addition, the company exports its products. Bajaj HealthCare Limited was incorporated in 1993 and is based in Thane, India.
Technical Analysis
Bliss Gvs Pharma Limited
―
Hester Biosciences Limited
―
Jagsonpal Pharmaceuticals Ltd.
―
Syncom Formulation (India) Ltd.
―
Themis Medicare Limited
―